2m 2m 2m 2m 2m 2m 2m
AURA BIOSCIS (AURA)
NASDAQ
$7.00$0.00 (0.00%)
Price as of Sep 11, 2026 7:30 PM EDT- $725.4MMarket Cap
- 13.19%1-Year Change
- BiotechnologyIndustry
AURA BIOSCIS (AURA)
$7.00$0.00 (0.00%)
AURA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $7.00 | ||
Change | +$0.005 (+0.07%) | ||
Open | $7.08 | ||
High | $7.08 | ||
Low | $6.91 | ||
Previous Close | $6.99 | ||
Volume | 830,842 | ||
30-Day Average Volume | 836,259 | ||
1-Week Change | -7.47% | ||
1-Month Change | -13.00% | ||
1-Year Change | 13.19% | ||
3-Year Change | -32.22% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 103.7M | ||
Total Assets | $348.1M | ||
Market Cap | $725.4M | ||
Enterprise Value | $657.6M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$45.6M | ||
Free Cash Flow | -$32.5M | ||
EBIT | -$45.6M | ||
EBITDA | -$45.3M | ||
Net Working Capital | $309.5M | ||
EPS | -$0.48 | ||
Enterprise Value/EBITDA | -15 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -15 | ||
PEG | -4 | ||
Price/Free Cash Flow | -22 | ||
Price/Operating Cash Flow | -22 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue